GC CELL CORPORATION Logo

GC CELL CORPORATION

Cell and gene therapy specialist with integrated CDMO, bio-logistics, and cell banking.

144510 | KO

Overview

Corporate Details

ISIN(s):
KR7144510005
LEI:
Country:
South Korea
Address:
경기도 용인시 기흥구 이현로30번길 107, 용인시

Description

GC CELL CORPORATION specializes in cell and gene therapy, providing a fully integrated value chain from research to commercialization. The company's core offerings include end-to-end Contract Development and Manufacturing Organization (CDMO) services for autologous and allogeneic cell therapies, comprehensive bio-logistics, and cell banking. Its integrated model supports partners throughout the entire drug life cycle, from initial development and manufacturing to clinical trials and commercial distribution. In addition to its service-based solutions, GC CELL develops proprietary cell therapy products, including Immuncell-LC, an adjuvant therapy for hepatocellular carcinoma. The company focuses on advancing treatments in areas such as immune-oncology and delivering customized solutions to enhance patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 3.0 MB
2025-08-01 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.5 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.8 MB
2025-05-12 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-04-30 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.5 KB
2025-04-30 00:00
소속부변경
Korean 3.6 KB
2025-04-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.0 KB
2025-04-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.0 KB
2025-04-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.0 KB
2025-04-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.0 KB
2025-04-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-03-25 00:00
대표이사변경
Korean 10.6 KB
2025-03-25 00:00
정기주주총회결과
Korean 21.1 KB

Automate Your Workflow. Get a real-time feed of all GC CELL CORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GC CELL CORPORATION

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GC CELL CORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.